assess-target-drug-bd-opportunities-ls

Integrate target biology, disease rationale, drug pipeline, clinical, patent, scientific, regulatory, company, and transaction evidence for target or targeted-asset R&D and business-development decisions. Use for target initiation reviews, asset or modality opportunity screens, partnering theses, target landscape updates, and evidence-based go/no-go conditi…

Independent GitHub snapshot · Automated classification · Original documentation governs